Meta-Flux

Startup

Meta-Flux is a Dublin-based tech-bio company building AI for pre-clinical R&D, turning complex biology into actionable decisions. We integrate mechanistic data and peer-reviewed literature with graph neural networks, agentic LLMs, and natural-language search to construct multi-omic disease maps. Teams use Meta-Flux to accelerate target discovery, clarify mechanism of action, profile off-targets, and de-risk preclinical paths across oncology, autoimmune, and neurodegenerative programs.

For vaccine developers, Meta-Flux supports:

• MoA-centric antigen and adjuvant hypothesis generation

• Immune-pathway mapping to understand responders vs non-responders and stratify cohorts

• Safety signal triage to surface early red flags

• Literature-to-lab bridging that compresses time from idea to in-silico evidence

Our platform is built for small-n through large-scale datasets and is adaptable to bespoke pipelines, enabling transparent reasoning and IP-aligned workflows.

website